Apellis Pharmaceuticals Statistics
Total Valuation
APLS has a market cap or net worth of $3.00 billion. The enterprise value is $3.08 billion.
Important Dates
The last earnings date was Thursday, July 31, 2025, before market open.
Earnings Date | Jul 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
APLS has 126.29 million shares outstanding. The number of shares has increased by 2.43% in one year.
Current Share Class | 126.29M |
Shares Outstanding | 126.29M |
Shares Change (YoY) | +2.43% |
Shares Change (QoQ) | +0.46% |
Owned by Insiders (%) | 3.32% |
Owned by Institutions (%) | 78.78% |
Float | 78.12M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 4.01 |
Forward PS | 2.93 |
PB Ratio | 19.54 |
P/TBV Ratio | 19.12 |
P/FCF Ratio | 677.23 |
P/OCF Ratio | 665.62 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 4.09 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 698.75 |
Financial Position
The company has a current ratio of 3.77, with a Debt / Equity ratio of 3.01.
Current Ratio | 3.77 |
Quick Ratio | 3.01 |
Debt / Equity | 3.01 |
Debt / EBITDA | n/a |
Debt / FCF | 106.43 |
Interest Coverage | -4.11 |
Financial Efficiency
Return on equity (ROE) is -108.49% and return on invested capital (ROIC) is -17.41%.
Return on Equity (ROE) | -108.49% |
Return on Assets (ROA) | -13.77% |
Return on Invested Capital (ROIC) | -17.41% |
Return on Capital Employed (ROCE) | -30.62% |
Revenue Per Employee | $1.06M |
Profits Per Employee | -$321,372 |
Employee Count | 710 |
Asset Turnover | 0.87 |
Inventory Turnover | 3.11 |
Taxes
In the past 12 months, APLS has paid $1.69 million in taxes.
Income Tax | 1.69M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.98% in the last 52 weeks. The beta is 0.77, so APLS's price volatility has been lower than the market average.
Beta (5Y) | 0.77 |
52-Week Price Change | -29.98% |
50-Day Moving Average | 19.15 |
200-Day Moving Average | 24.59 |
Relative Strength Index (RSI) | 70.96 |
Average Volume (20 Days) | 2,861,588 |
Short Selling Information
The latest short interest is 16.49 million, so 13.06% of the outstanding shares have been sold short.
Short Interest | 16.49M |
Short Previous Month | 26.15M |
Short % of Shares Out | 13.06% |
Short % of Float | 21.11% |
Short Ratio (days to cover) | 8.59 |
Income Statement
In the last 12 months, APLS had revenue of $754.65 million and -$228.17 million in losses. Loss per share was -$1.82.
Revenue | 754.65M |
Gross Profit | 313.89M |
Operating Income | -190.06M |
Pretax Income | -330.95M |
Net Income | -228.17M |
EBITDA | -188.26M |
EBIT | -190.06M |
Loss Per Share | -$1.82 |
Full Income Statement Balance Sheet
The company has $374.78 million in cash and $469.77 million in debt, giving a net cash position of -$94.99 million or -$0.75 per share.
Cash & Cash Equivalents | 374.78M |
Total Debt | 469.77M |
Net Cash | -94.99M |
Net Cash Per Share | -$0.75 |
Equity (Book Value) | 156.31M |
Book Value Per Share | 1.24 |
Working Capital | 554.95M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $4.49 million and capital expenditures -$77,000, giving a free cash flow of $4.41 million.
Operating Cash Flow | 4.49M |
Capital Expenditures | -77,000 |
Free Cash Flow | 4.41M |
FCF Per Share | $0.03 |
Full Cash Flow Statement Margins
Gross margin is 41.59%, with operating and profit margins of -25.19% and -30.24%.
Gross Margin | 41.59% |
Operating Margin | -25.19% |
Pretax Margin | -30.01% |
Profit Margin | -30.24% |
EBITDA Margin | -24.95% |
EBIT Margin | -25.19% |
FCF Margin | 0.58% |
Dividends & Yields
APLS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.43% |
Shareholder Yield | -2.43% |
Earnings Yield | -7.63% |
FCF Yield | 0.15% |
Dividend Details Analyst Forecast
The average price target for APLS is $34.11, which is 43.74% higher than the current price. The consensus rating is "Buy".
Price Target | $34.11 |
Price Target Difference | 43.74% |
Analyst Consensus | Buy |
Analyst Count | 20 |
Revenue Growth Forecast (5Y) | 16.24% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
APLS has an Altman Z-Score of -1.27 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.27 |
Piotroski F-Score | 5 |